Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/65206
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHull, M.en
dc.contributor.authorPrentice, A.en
dc.contributor.authorWang, D.en
dc.contributor.authorButt, R.en
dc.contributor.authorPhillips, S.en
dc.contributor.authorSmith, S.en
dc.contributor.authorCharnock-Jones, D.en
dc.date.issued2005en
dc.identifier.citationHuman Reproduction, 2005; 20(2):350-358en
dc.identifier.issn0268-1161en
dc.identifier.issn1460-2350en
dc.identifier.urihttp://hdl.handle.net/2440/65206-
dc.description.abstractBACKGROUND: Women with endometriosis have elevated levels of cyclooxygenase-2 (COX-2) in peritoneal macrophages and endometriotic tissue. Inhibition of COX-2 has been shown to reduce inflammation, angiogenesis and cellular proliferation. It may also downregulate aromatase activity in ectopic endometrial lesions. Ectopic endometrial establishment and growth are therefore likely to be suppressed in the presence of COX-2 inhibitors. We hypothesized that COX-2 inhibition would reduce the size and number of ectopic human endometrial lesions in a nude mouse model of endometriosis. METHODS: The selective COX-2 inhibitor, nimesulide, was administered to estrogen-supplemented nude mice implanted with human endometrial tissue. Ten days after implantation, the number and size of ectopic endometrial lesions were evaluated and compared with lesions from a control group. Immunohistochemical assessment of vascular development and macrophage and myofibroblast infiltration in control and treated lesions was performed. RESULTS: There was no difference in the number or size of ectopic endometrial lesions in control and nimesulide-treated nude mice. Nimesulide did not induce a visually identifiable difference in blood vessel development or macrophage or myofibroblast infiltration in nude mouse explants. CONCLUSION: The hypothesized biological properties of COX-2 inhibition did not influence lesion number or size in the nude mouse model of endometriosis.en
dc.description.statementofresponsibilityM.L.Hull, A.Prentice, D.Y.Wang, R.P.Butt, S.C.Phillips, S.K.Smith and D.S.Charnock-Jonesen
dc.language.isoenen
dc.publisherOxford University Pressen
dc.rights© European Society of Human Reproduction and Embryology 2004; all rights reserveden
dc.subjectCOX-2 inhibitor; endometriosis; mouse model; nimesulide; prostaglandinen
dc.titleNimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosisen
dc.typeJournal articleen
dc.identifier.doi10.1093/humrep/deh611en
pubs.publication-statusPublisheden
dc.identifier.orcidHull, M. [0000-0003-1813-3971]en
Appears in Collections:Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.